Cargando…
Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis complex mycobacteria. Extrapulmonary tuberculosis usually develops more than two years after infection or many years later. Factors favoring onset of the disease are malnutrition, older age, renal failure, diabetes, cancer, i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847295/ https://www.ncbi.nlm.nih.gov/pubmed/27407244 http://dx.doi.org/10.5114/reum.2015.53139 |
_version_ | 1782429186557739008 |
---|---|
author | Bielewicz-Zielińska, Agnieszka Brzezicki, Jan Rymko, Marcin Jeka, Sławomir |
author_facet | Bielewicz-Zielińska, Agnieszka Brzezicki, Jan Rymko, Marcin Jeka, Sławomir |
author_sort | Bielewicz-Zielińska, Agnieszka |
collection | PubMed |
description | Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis complex mycobacteria. Extrapulmonary tuberculosis usually develops more than two years after infection or many years later. Factors favoring onset of the disease are malnutrition, older age, renal failure, diabetes, cancer, immunosuppression and biological treatment, e.g. tumor necrosis factor α (TNF-α) inhibitors. The paper presents a case of a 56-year-old patient with ankylosing spondylitis treated with infliximab, diagnosed with tuberculosis of the spleen. The unusual location and uncharacteristic symptoms created a lot of diagnostic difficulties, particularly as during qualification for biological treatment tests are performed to exclude infection with Mycobacterium tuberculosis. Pharmacological treatment of tuberculosis is typical, but in the case of tuberculosis of the spleen, splenectomy also is a method of treatment. The decision was made to implement pharmacological treatment, which proved to be effective, so the patient avoided surgery. |
format | Online Article Text |
id | pubmed-4847295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie |
record_format | MEDLINE/PubMed |
spelling | pubmed-48472952016-07-12 Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy Bielewicz-Zielińska, Agnieszka Brzezicki, Jan Rymko, Marcin Jeka, Sławomir Reumatologia Case Reports Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis complex mycobacteria. Extrapulmonary tuberculosis usually develops more than two years after infection or many years later. Factors favoring onset of the disease are malnutrition, older age, renal failure, diabetes, cancer, immunosuppression and biological treatment, e.g. tumor necrosis factor α (TNF-α) inhibitors. The paper presents a case of a 56-year-old patient with ankylosing spondylitis treated with infliximab, diagnosed with tuberculosis of the spleen. The unusual location and uncharacteristic symptoms created a lot of diagnostic difficulties, particularly as during qualification for biological treatment tests are performed to exclude infection with Mycobacterium tuberculosis. Pharmacological treatment of tuberculosis is typical, but in the case of tuberculosis of the spleen, splenectomy also is a method of treatment. The decision was made to implement pharmacological treatment, which proved to be effective, so the patient avoided surgery. Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015-08-07 2015 /pmc/articles/PMC4847295/ /pubmed/27407244 http://dx.doi.org/10.5114/reum.2015.53139 Text en Copyright © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015 http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Case Reports Bielewicz-Zielińska, Agnieszka Brzezicki, Jan Rymko, Marcin Jeka, Sławomir Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy |
title | Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy |
title_full | Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy |
title_fullStr | Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy |
title_full_unstemmed | Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy |
title_short | Unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy |
title_sort | unusual location of tuberculosis in the course of tumor necrosis factor α inhibitor therapy |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847295/ https://www.ncbi.nlm.nih.gov/pubmed/27407244 http://dx.doi.org/10.5114/reum.2015.53139 |
work_keys_str_mv | AT bielewiczzielinskaagnieszka unusuallocationoftuberculosisinthecourseoftumornecrosisfactorainhibitortherapy AT brzezickijan unusuallocationoftuberculosisinthecourseoftumornecrosisfactorainhibitortherapy AT rymkomarcin unusuallocationoftuberculosisinthecourseoftumornecrosisfactorainhibitortherapy AT jekasławomir unusuallocationoftuberculosisinthecourseoftumornecrosisfactorainhibitortherapy |